Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation

Author:  ["J. Ryan Gunsalus","Deborah A. Brady","Sarah M. Coulter","Brian M. Gray","Albert S.B. Edge"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Transplantation of xenogeneic hepatocytes would provide a novel therapy for liver disease and would help to solve the problem of an insufficient supply of donor organs. We have tested whether xenogeneic cells infused into the liver could correct the metabolic defect in the Watanabe heritable hyperlipidemic (WHHL) rabbit, an animal model for homozygous familial hypercholesterolemia, and we have investigated whether the infused cells traverse the lining of the portal vasculature. We find that porcine hepatocytes are localized in the hepatic sinusoids after surgery and subsequently migrate out of the vessels and integrate into the hepatic parenchyma. The integrated porcine hepatocytes provide functional LDL receptors that lower serum cholesterol in the WHHL rabbit by 30–60% for at least 100 days.

Cite this article

Gunsalus, J., Brady, D., Coulter, S. et al. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation. Nat Med 3, 48–53 (1997). https://doi.org/10.1038/nm0197-48

View full text

>> Full Text:   Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation

Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line ba

Myelination of the canine central nervous system by glial cell transplantation: A model for repair o